News / Blog
New Year Holidays 2024 / 2025
Catalog
Seebri Inhalation Capsules 50mcg (bronchitis, emphysema)
Product Code :
Availability : 12
USD 89.00
General information on Japanese Seebri Inhalation Capsules 50 mcg
Package details: 28 doses
Manufacturer: Meiji Seika Pharma Co., Ltd., Japan
Active ingredient: glycopyrronium bromide (chemical formula C19H28BrNO3)
Medical effect: Seebri inhalation capsules are effective for inducing:
- remission of symptoms caused by airway obstructive disorder,
- chronic obstructive pulmonary disease,
- chronic bronchitis,
- emphysema.
Contraindications and precautions: do not use in patients with angle-closure glaucoma and difficulty in urination due to prostate hypertrophy. Do not use in pregnant or breastfeeding women.
Dosage and administration of Japanese Seebri Inhalation Capsules 50mcg
Inhale 1 capsule (50 mcg of the active ingredient) a time, 1 time a day, using a special inhaler designed for capsules at a regular time every day. Never take the capsule orally. Do not store capsules inside the inhaler. If you don’t have an inhaler designed for capsule, it’s possible to use them with inhaler designed for powder. Open the capsule and insert its content inside the inhaler.
Take out the capsule from the aluminum package (blister package) immediately before using it. Be sure to prevent this medicine from getting into the eye.
How effective are Seebri Inhalation Capsules 50mcg from Japan?
Seebri inhalation capsules contain glycopyrronium bromide, a long acting muscarinic receptor antagonist. It helps to improve respiratory function by dilating bronchi over a long time. Studies have shown that glycopyrronium produces rapid and sustained bronchodilation with an efficacy similar to tiotropium and is well tolerated, with a low incidence of muscarinic side effects (Anoop Prakash, K. Suresh Babu, Jaymin B. Morjaria. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 2015; 10: 111–123).
Who should use Seebri Inhalation Capsules 50mcg?
Seebri inhalation capsules are effective for the treatment of patients with moderate to severe chronic obstructive pulmonary disease (chronic bronchitis, emphysema). This medicine relieves symptoms caused by airway obstructive disorder. The capsules should be routinely inhaled every day, therefore, the medicine does not provide prompt relief of acute progression of the symptoms.




